Previous research suggested that a key factor contributing to the pathological phenotype in SMA is the lowered expression of the Igf1/Igfbp3/Igfals genes, which produce IGF and IGF-carrying proteins, in the liver (Hua et al., 2011; Murdocca et al., 2012). Here, IGF1 is linked to proximal spinal muscular atrophy.